SHERRI VAN EVEREN, PharmD has been a member of the Board since January 2015 and been instrumental in leading the research strategy for JMCDF. She has been in Ophthalmology research for over 15 years and was instrumental in helping initiate the Jack McGovern Coats’ Disease collaboration with Genentech. Currently, she is Vice President of Ophthalmology Clinical Development at REGENXBIO, Inc. developing gene therapies for patients with unmet needs. In addition to participating on the Board and serving as Chair of the Jack McGovern Coats’ Disease Foundation Scientific Advisory Board, Sherri leads our Foundation’s scientific initiatives, including setting up a patient registry and supporting additional research collaborations in Coats’ Disease.